Gene expression analysis on small numbers of invasive cells collected by chemotaxis from primary mammary tumors of the mouse by Wang, Weigang et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
BMC Biotechnology
Open Access Methodology article
Gene expression analysis on small numbers of invasive cells 
collected by chemotaxis from primary mammary tumors of the 
mouse
Weigang Wang*1, Jeffrey B Wyckoff1, Yarong Wang1, Erwin P Bottinger2, 
Jeffrey E Segall1 and John S Condeelis1
Address: 1Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA and 2Department of 
Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA
Email: Weigang Wang* - wgwang@aecom.yu.edu; Jeffrey B Wyckoff - jwyckoff@aecom.yu.edu; Yarong Wang - yarwang@aecom.yu.edu; 
Erwin P Bottinger - bottinge@aecom.yu.edu; Jeffrey E Segall - segall@aecom.yu.edu; John S Condeelis - condeeli@aecom.yu.edu
* Corresponding author    
Abstract
Background: cDNA microarrays have the potential to identify the genes involved in invasion and
metastasis. However, when used with whole tumor tissue, the results average the expression
patterns of different cell types. We have combined chemotaxis-based cell collection of the invasive
subpopulation of cells within the primary tumor with array-based gene expression analysis to
identify the genes necessary for the process of carcinoma cell invasion.
Results: Invasive cells were collected from live primary tumors using microneedles containing
chemotactic growth factors to mimic chemotactic signals thought to be present in the primary
tumor. When used with mammary tumors of rats and mice, carcinoma cells and macrophages
constitute the invasive cell population. Microbeads conjugated with monoclonal anti-CD11b (Mac-
1α) antibodies were used to separate macrophages from carcinoma cells. We utilized PCR-based
cDNA amplification from small number of cells and compared it to the quality and complexity of
conventionally generated cDNA to determine if amplified cDNA could be used with fidelity for
array analysis of this cell population. These techniques showed a very high level of correlation
indicating that the PCR based amplification technique yields a cDNA population that resembles,
with high fidelity, the original template population present in the small number of cells used to
prepare the cDNA for use with the chip.
Conclusions: The specific collection of invasive cells from a primary tumor and the analysis of
gene expression in these cells are is now possible. By further comparing the gene expression
patterns of cells collected by invasion into microneedles with that of carcinoma cells obtained from
the whole primary tumor, the blood, and whole metastatic tumors, genes that contribute to the
invasive process in carcinoma cells may be identified.
Background
In spite of advances in screening and adjuvant therapy,
breast cancer continues to be a major health problem.
Once cancer cells have spread and formed metastases,
breast cancers are largely incurable even with state-of-the-
art medicine. Understanding how cancer cells spread to
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other parts of the body can provide important insights
and will ultimately translate into improved diagnostic,
prognostic and therapeutic approaches that allow control
of cancer metastasis. Recently, emphasis has been on the
development of molecular arrays to identify new genes
and proteins that contribute to specific steps in metastasis
[1,2]. Large-scale nucleic acid arrays have become very
useful tools for investigators exploring differences in gene
expression between cell types, stages of differentiation,
and cellular responses to stimuli [3]. Such approaches are
crucial in the analysis of cancer as a genetic disease and in
the identification of key genes that might be used in diag-
nosis and therapy. So far, most gene expression studies
have been done using whole tumor tissue. However,
human primary tumors show extensive variation in all
properties ranging from growth and morphology of the
tumor, and formation and growth of metastases, and the
application of tissue homogenates results inevitably in
averaging of the expression of different cell types. The
expression profile of tumor cells essential for invasion
may be masked or even lost due to the contributions of
surrounding cells. It is important to develop a technology
to separate pure populations of invasive cancer cells for
gene expression studies. The use of Laser Capture Micro-
dissection as a front end for array-based gene discovery is
such an approach. However, some of the cell behaviors
that are believed to be essential for metastasis, such as
adhesion and motility, cannot be used as criteria in the
selection of cells for analysis from fixed material because
the behavior and history of individual cells cannot be
inferred from fixed material. Methods for the collection of
cells from living tumors in which key cell behaviors can be
observed and used as the criteria for cell collection need to
be developed. An important approach in determining the
cellular mechanisms that contribute to metastasis is to
collect live cells from the primary tumor based on proper-
ties believed necessary for successful metastasis. We have
shown previously that one of the properties correlated
with metastasis is chemotaxis to blood vessels [4]. This
cell behavior allows cells to orient and move toward
blood vessels facilitating their intravasation. We have
developed a method to selectively collect invasive cells
from live primary tumors in intact rats using a micronee-
dle containing a chemoattractant to mimic chemotactic
signals from blood vessels and/or surrounding tissue [5].
For the study of the invasive subpopulation of cells within
the primary tumor, the combination of chemotaxis-based
cell collection in microneedles with array-based gene
expression analysis has the potential to identify the genes
necessary for the individual steps of invasion at the cellu-
lar level, and for the rational interpretation of gene expres-
sion patterns in metastatic tumors. One drawback to the
array technique is the need to isolate and purify micro-
gram amounts of total RNA [6] to generate the appropri-
ate amounts of probe needed for conventional
microarrays. However, the number of cells collected from
mammary tumors with microneedles in vivo is currently
limited to fewer than 1000 per needle. This number of
cells typically contains 20–50 ng of total RNA [7,8], well
below the amounts needed for conventional array proto-
cols. In order to combine the collection of invasive cells
from live animals with cDNA arrays technology, we have
experimented with a number of methods that have been
used to amplify the starting RNA in other applications [9].
We have found that the SMART PCR cDNA amplification
method (ClonTech Laboratories) can be used in gene
expression profiling experiments to produce cDNA librar-
ies from total RNA that are representative of the starting
mRNA. This has the potential to allow the routine analysis
of differential gene expression in very small tissue samples
[10–12]. Key to this alternative approach is the reproduc-
ible and representative synthesis of cDNA probes that
retain faithfully the complexity of the mRNA population
present in the original sample [9]. In this study we com-
pared two approaches for synthesizing cDNA probes from
total RNA for use with subsequent hybridization to high-
density cDNA microarrays: 1) the conventional approach
of reverse transcription (RT) of 100 µg of total RNA from
cultures of carcinoma cells and 2) amplification of ~30 ng
of total RNA from 1000 carcinoma cells using the PCR
based cDNA amplification system. The results reported
here demonstrate that, for situations with limited RNA,
the RT-PCR based probe synthesis method retains the
original mRNA message profile, and is suitable for gene
expression profiling of invasive cells collected in
microneedles.
The efficiency of separation of the pure population of
invasive carcinoma cells and the quality of RNA isolated
from microneedles were also tested in this study.
Results
Separation of carcinoma cells and macrophages for use in 
microarray analysis
As shown by our group elsewhere [13], the invasive cells
that enter microneedles in the primary tumor are a mix-
ture of macrophages and carcinoma cells. This conclusion
is based on both cell type-specific antibody staining and
real time PCR using cell type-specific primers. In order to
analyze the gene expression pattern of only a single cell
type at a time, we have investigated the efficiency of sepa-
rating these two cell types using standard techniques. As
shown in Figure 1A and 1B based on cell type-specific
antibody staining, the use of MAC 1 antibody-coated
magnetic beads can be used to selectively remove the mac-
rophage sub-population of cells from the carcinoma cells
collected in a single microneedle. The separation allows
removal 80% of the macrophage contribution. The ability
to separate the macrophages is further demonstrated byBMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/13
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1A and 1B: Macrophages can be separated from carcinoma cells after microneedle collection Figure 1
1A and 1B: Macrophages can be separated from carcinoma cells after microneedle collection. Cells collected 
from a MMTV-PyMT primary tumor in a microneedle filled with matrigel and 25 nM EGF were magnetically separated using 
Mac-1 coated iron beads. Approximately 80% of the macrophages were removed from the sample, leaving only a 6% contami-
nation of the carcinoma cell population by macrophages after a single separation step. 
Figure 1C: Quantitative real-time PCR shows a decrease in the amount of Mac-1 mRNA in cells separated 
after collection from the primary tumor. Cells were collected and separated as described in Materials and Methods. 
After RNA purification from cells before and after separation, real-time PCR was run for the Mac-1 (macrophage marker) and 
keratin 18 (carcinoma cell marker) primers. Normalization was done using β-actin as reference gene. A decrease in expression 
of Mac-1 is seen in the cell-separated sample compared to that of the sample containing both cell types. This further confirms 
our ability to reduce the contaminating cells from our collected sample, so as to have a pure carcinoma cell population for gene 
discovery. The level of Keratin 18 expression shows a slight increase after separation.BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/13
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comparing quantitative real time PCR using cell type-spe-
cific primers to the results of real time PCR on samples
after removal of the macrophages by the use of magnetic
beads (Fig 1C). Again, real time PCR demonstrates the
extensive removal of the macrophage-specific marker,
yielding a purer carcinoma cell population for further
analysis.
Characterization of cDNA amplification techniques
We have adopted a SMART (Switch Mechanism At the 5'
end of RNA Transcript) amplification method [14,15] to
amplify cDNA from our needle collection cells. Key to this
alternative approach is the reproducible and representa-
tive synthesis of cDNA probes that retain faithfully the
complexity of the mRNA population present in the origi-
nal sample [9]. In this study we compared two approaches
for synthesizing cDNA probes from total RNA for use with
subsequent hybridization to high-density cDNA microar-
rays: 1) the conventional approach of reverse transcrip-
tion (RT) of 100 µg of total RNA from cultures of
carcinoma cells and 2) amplification of ~30 ng of total
RNA from 1000 carcinoma cells using the PCR based
cDNA amplification system.
Selection of the number of cycles for the exponential PCR
amplification of the cDNA is the crucial point of the tech-
nique. 10 µl aliquots from the amplification reactions
after 17, 20, 23 cycles were analyzed in a 1% agarose gel.
Overcycled reactions can be identified by the disappear-
ance of the distinct bands corresponding cDNAs and the
increased smear molecular weight. In this study, prepara-
tive amplifications were subsequently performed at 20
cycles for cells from culture and microneedle.
As shown in Figure 2, comparison of the relative expres-
sion level of six genes in a metastatic cell line (MTLn3)
and the non-metastatic cell line (MTC) was done using
real time PCR. The amplified RNA shows the similar rela-
tive level of expression as unamplified RNA indicating
that the PCR based cDNA amplification technique does
not give rise to a misrepresentation of the original tem-
plate complexity of RNA isolated from small numbers of
cells.
By comparing the distribution of ratios of gene expression
in a metastatic cell line (MTLn3) and the non-metastatic
cell line (MTC), it was possible to establish the relatedness
of the expression patterns of the two cell types on a 9000
gene chip. As shown in Figure 3, the correlation of the
expression ratios allows one to establish the reproducibil-
ity and relatedness of the preparations of cDNA. In Figure
3A, RNA isolated from ten million cells of each cell line
was used to prepare the cDNA probe for use in the array.
As shown in Fig 3A, comparison of two separate chips
probed with unamplified sample shows a correlation
coefficient of greater than 0.91. We then evaluated ampli-
fication of RNA from 1000 cells, followed by hybridiza-
tion to two microarrays (Figure 3B). The amplified RNA
samples showed a correlation coefficient in excess of 0.93
indicating that this technique generates a highly reproduc-
ible cDNA product. Finally, the average ratio of expression
patterns for each gene in 3A and 3B are plotted in Figure
3C and show a correlation in excess of 0.9. This indicates
that the PCR based amplification technique yields a cDNA
population that resembles with high fidelity the original
template population present in the small number of cells
used.
This conclusion is supported by the data in Figure 4, in
which the level of expression of a select number of over-
expressed genes identified initially in unamplified RNA
was also found to be over-expressed in chips probed with
amplified cDNA. All of these results indicate that the PCR
based cDNA amplification technique is eminently suita-
ble for use with small numbers of cells as those obtained
using needle collection.
Relative abundance of genes is maintained during cDNA  amplification as verified by Quantitative real-time PCR Figure 2
Relative abundance of genes is maintained during 
cDNA amplification as verified by Quantitative real-
time PCR. cDNA from 1000 MTLn3 (a metastatic cell line) 
or 1000 MTC cells (non-metastatic cell line) was diluted 
(1:10) after 20 cycles of SMART PCR amplification, and the 
expression of selected genes was compared with cDNA 
from 3 µg unamplified total RNA from MTLn3 or MTC cells 
by real-time PCR.BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/13
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The correlation coefficient demonstrates that amplified cDNA is comparable to that of conventionally isolated RNA from large  numbers of cells Figure 3
The correlation coefficient demonstrates that amplified cDNA is comparable to that of conventionally isolated 
RNA from large numbers of cells. A) By comparing the distribution of ratios of gene expression in MTLn3 and MTC, the 
relatedness of the expression patterns of the two cell types is establish on a 9000 gene chip. Log base 2 ratios from 2 chips 
were plotted for unamplified probes from MTLn3 and MTC cells. B) Log base 2 ratios from 2 chips using PCR amplified probes 
of MTLn3 and MTC cells shows a higher correlation coefficient. C) The mean of the log base 2 ratios in A and B shows a cor-
relation coefficient within the accepted range for conventional RNA methods.BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/13
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Use of PCR based cDNA amplification with cells collected 
in microneedles from the primary tumor
RNA quality is an important issue for gene expression
analysis. As shown in Fig 5A, total RNA isolated from
microneedle collected cells was checked using the Agilent
Bioanalyzer and the RNA 6000 Pico kit. The RNA 6000
Pico kit used here allows the determination of the integ-
rity of very low amount of RNA as well as an estimation of
the amount of the isolated RNA. The size distribution and
rRNA ratio (28S/18S = 2.7) indicates good intactness of
RNA sample. Furthermore, validation of the RNA quality
using the relative abundance of the marker template, beta-
actin mRNA, demonstrates that the amount of the mRNA
template isolated from cells in the collection needle was
identical to that of RNA isolated conventionally from cells
obtained from the whole primary tumor (Figure 5B).
In order to study the gene expression patterns of invasive
cells collected from the primary tumor using micronee-
dles, we amplified RNA from the cells collected in a single
microneedle in the primary tumor. Amplification of the
RNA from 800 cells collected in a microneedle yielded a
pattern of PCR products with a size complexity that was
very similar to the size complexity of the PCR product
obtained from one thousand cultured carcinoma cells (Fig
6A). Figure 6B demonstrates the use of the cDNA ampli-
fied from cells collected in a microneedle from the pri-
mary tumor in probing a high-density cDNA microarray.
More than 91% of the spots showed a good hybridization
signal. Finally, as shown in Figure 6C, the distribution dia-
gram shows a similar distribution of gene expression pat-
terns for amplified samples indicating the cDNA prepared
from the small number of cells is of sufficient quality and
complexity to be useful in probing the nine thousand
genes present in this high-density array.
Discussion
Microneedle collection
In our previous study [5], we reported that needles con-
taining chemoattractants can be used to collect the
subpopulation of motile and chemotactic tumor cells
from a primary tumor in vivo as a population suitable for
further analysis. It suggests that needles filled with growth
factors and matrigel, when inserted into the primary
tumor, can faithfully mimic the environment that sup-
ports invasion and intravasation in vivo, and that the same
cell behaviors that contribute to chemotaxis in vitro also
contribute to invasion in vivo.
An advantage of using the needle collection technique
described here for the collection of cells for genomic/pro-
teomic analysis is that the cell behavior can be character-
ized during the collection process. This can be done by
varying the conditions required for cell collection such as
the extracellular matrix composition and/or cytokines
used as chemoattractants, determining how these changes
affect efficiency of cell collection, and then relating these
observations to the gene expression and protein composi-
tion patterns subsequently obtained from array analysis of
the collected cells. Furthermore, cells can also be charac-
terized by intravital imaging during collection to directly
visualize the cell-cell and cell-extracellular matrix interac-
tions that contribute to the invasion of the needle under
these different conditions [16]. In addition, cells could be
cultured and transplanted into other host animals to
determine whether they stably retain differential charac-
teristics that contribute to metastatic potential. Finally, by
comparing the gene expression patterns of cells collected
by invasion into needles with that of cells obtained from
the whole primary tumor, the blood, and whole meta-
static tumors, genes that contribute to the invasive process
uniquely may be identified.
Separation of macrophages from the microneedle 
collection samples also makes it possible to analyze the 
gene expression pattern of Tumor Associated 
Macrophages
The tumor microenvironment contains stromal cells that
influence the behavior of the tumor. Of these, there is
increasing evidence that macrophages play an important
role in modulating the metastatic capacity of the tumor.
This includes clinical evidence showing a strong
correlation between TAM (Tumor Associated Macro-
phages) [17,18] and poor prognosis, and genetic studies
Cancer metastasis genes overexpressed in MTLn3 cells are  detected by both probe synthesis techniques Figure 4
Cancer metastasis genes overexpressed in MTLn3 
cells are detected by both probe synthesis tech-
niques. Amplified cDNA probe from MTLn3 cells and MTC 
cells were hybridized to a 9000 gene cDNA microarray. 
When compared to a chip hybridized with probes generated 
from unamplified RNA, the level of expression for selected 
metastasis genes are seen to show similar levels of expres-
sion on the amplified cDNA probe chip.BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/13
Page 7 of 12
(page number not for citation purposes)
The RNA from 200 and 400 cells is of equal amount and quality to RNA purified by conventional methods Figure 5
The RNA from 200 and 400 cells is of equal amount and quality of RNA purified by conventional methods. Fig-
ure 5A: Total RNA isolated from microneedle collected cells was checked using Agilent Bioanalyzer and RNA 6000 Pico kit. 
The size distribution and rRNA ratio (28S/18S = 2.7) indicates good intactness of RNA sample. Figure 5B: A standard curve 
was generated for the CT value of a known quantity of RNA from a specific cell number using the β-actin primers for real-time 
PCR. The RNA from 200 and 400 cells were amplified by the SMART PCR method and run identically by real-time PCR. The 
CT values for the amplified RNA fall on the curve showing that the appropriate amount of the house keeping gene is present in 
the amplified sample. The CT values for the amplified samples are designated by the red asterisks.BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/13
Page 8 of 12
(page number not for citation purposes)
The RNA from microneedle collected cells was extracted and amplification was performed using SMART PCR Figure 6
The RNA from microneedle collected cells was extracted and amplification was performed using SMART PCR. Separately, 1µg 
of Universal Mouse Reference RNA (Stratagene) were used to generate reference cDNA. Fig 6A shows a gel picture of ampli-
fied cDNA from microneedle collected cells. The numbers indicate the PCR cycle number. The generated PCR product from 
the needle sample as well as the Universal Mouse Reference cDNA were labeled with Cy5 or Cy3. The two resulting cDNA 
probes were then mixed together and hybridized to a microarray slide containing 9700 genes. Fig 6B shows a part of the entire 
array (4 out of 16 blocks) generated using PCR amplified probe. Fig 6C is a histogram of the distribution of gene expression 
(CY5/Cy3) ratios for the array elements for hybridizations comparing gene expression.BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/13
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in mice where removal of macrophages from the tumor
bed leads to severely reduced rates of metastasis [19,20].
Macrophages may contribute factors that affect tumor
progression by altering the microenvironment including
angiogenic and proteolytic factors [19]. These cells are
also capable of producing many growth factors, including
members of the EGF-family, which directly influence the
behavior of tumor cells. In wound healing or at sites of
infection, macrophages synthesize chemotactic factors
that recruit other blood cells. The unique ability of macro-
phages to localize to specific sites and perform such tasks
suggests that they could also provide chemotactic cues in
tumors promoting the egress of the carcinoma cells from
the tumor core. The collection of macrophages with carci-
noma cells into microneedles in response to EGF is con-
sistent with a role for macrophages in cancer cell invasion.
The methods described here allow for the collection of
invasive tumor cells and Tumor Associated Macrophages
and their separation into two cell types. These techniques
will allow us to analyze the gene expression pattern not
only for tumor cells but also for macrophages. It will make
possible the identification of paracrine and other micro-
environment-dependent interactions that contribute to
the invasive process.
RNA quality of microneedle collected cells
Integrity of RNA samples is essential in the context of
doing gene expression analysis on the microneedle col-
lected cells. The matrigel in the needle makes it difficult to
extract the RNA due to the abundance of proteins and col-
lagen. In order to remove these proteins, which can inter-
fere with the procedure, the standard RNeasy Mini
Protocol from animal tissue has been adapted to include
a proteinase K digest. After dilution of the lysate, the sam-
ple is treated with proteinase K. Debris is pelleted by cen-
trifugation. Ethanol is then added to the cleared lysate and
RNA is bound to the RNeasy membrane. This protocol has
been used successfully for RNA isolation from micronee-
dle collection samples and ensured high-quality RNA. As
shown in our result, total cellular RNA prepared from
microneedle collection samples remains intact after isola-
tion, increasing confidence in subsequent molecular
analyses.
PCR based cDNA amplification for use in microarray 
analysis of invasive carcinoma cells
PCR based cDNA amplification results in a cDNA product
that resembles the starting template in size hetero-disper-
sion and complexity. Amplified cDNA is of a quality suf-
ficient for use with high-density cDNA microarrays.
The specific collection of invasive cells from the primary
tumor and the analysis of gene expression in these cells is
now possible. We have demonstrated that RNA obtained
from as few as 400 cells collected in a microneedle from
the primary tumor, when amplified as cDNA using the
PCR based protocol, can be used for microarray expres-
sion analysis. We have further documented that calibra-
tion of the number of PCR cycles used in this method
allows amplification without loss of either relative mRNA
copy abundance or complexity of the amplified product.
This technology will allow the characterization of gene
expression patterns of invasive tumor cells within the pri-
mary tumor during invasion and in response to varying
genetic backgrounds. It will also make possible the
identification of paracrine and other microenvironment-
dependent interactions that contribute to the invasive
process.
Conclusions
The specific collection of invasive cells from the primary
tumor and the analysis of gene expression in these cells
are now possible. By further comparing the gene expres-
sion patterns of cells collected by invasion into micronee-
dles with that of carcinoma cells obtained from the whole
primary tumor, the blood, and whole metastatic tumors,
genes that contribute to the invasive process in carcinoma
cells may be identified.
Methods
Mice
All mice were created in the FVB-C3H/B6 background and
remained in a consistent background throughout
breeding. The origin and identification of MMTV-PyMT
has been described previously [20]. MMTV-GFP mice were
described previously [21] and crossed with the MMTV-
PyMT mice to produce GFP labeled tumors. Tumors were
allowed to grow for 16–18 weeks prior to cell collection to
ensure late stage carcinomas and increased metastasis.
Preparation and handling of collection needles
We have combined needle collection of invasive cells with
multiphoton-based intravital imaging in mice with mam-
mary tumors produced by the expression of the polyoma-
virus middle T oncogene. Expression of the polyomavirus
middle T antigen in the mammary gland (MMTV-PyMT)
results in transformation of the mammary epithelium and
the rapid production of multifocal mammary adenocarci-
nomas [22]. MMTV-MiddleT transgenic mice crossed with
MMTV-GFP transgenics were allowed to grow tumors for
16 weeks. On the day of the experiment 33-gauge needles
were prepared by filling them with 1:10 matrigel and L15-
BSA (the isotonic equivalent of 5% FBS), or L15-BSA with
a final concentration of 25nM EGF. All needles contained
0.01 mM EDTA (pH 7.4) to sequester heavy metals that
might be released from the needle. A mouse was
anesthetized using 5% isoflurane and laid on its back. The
isoflurane was reduced to 2 %, and a small patch of skin
was removed to expose the tumor. Three 25-gaugeBMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/13
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needles, with inserted blocking wires, were positioned
with the needle holder held in a micromanipulator for
stability, into the tumor. The guide wires were removed
and the matrigel containing needles were inserted. The
animal was kept under monitored anesthesia for 4 hours.
Afterwards, the needle contents were expelled onto a
cover slip, mixed 1:1 with DAPI and counted
immediately.
Macrophage separation from cultured cells
As described in our previous work [13], carcinoma cells
comprised approximately 73% of the total cell popula-
tion, while macrophages comprised 26%, together
accounting for over 99% of the cells collected in response
to EGF. To test the possibility of removing the macro-
phages from this total cell population, the following
experiment was performed. BAC-1.25 macrophages and
MTLn3-GFP adenocarcinoma cells grown in culture were
removed with PBS/ 2 mM EDTA, pH 7.5. After counting
cells, approximately 1000 carcinoma cells were mixed
with 350 macrophages in 90 µl of PBS/0.5% BSA/ 2
mMEDTA in a 500 µl eppendorf tube. Cells were then
mixed with 10 µl of MACS CD11b Microbeads (Miltenyi
Biotec). These microbeads are colloidal super-paramag-
netic beads conjugated with monoclonal anti-mouse
CD11b (Mac-1α) antibodies. The cells were placed at 4°C
for 15 min and then placed in a magnetic separator
(LifeSep HGS-1.5; Dexter Magnetic Technologies) for 15
min at 4°C. The supernatant was removed while still in
the magnetic separator and the cells were stained with
DAPI and counted immediately. Different cells types were
identified by their expression or lack of expression of GFP.
Macrophage separation from microneedle collected cells
Cells were collected from MMTV-PyMT mice. The needle
contents were extruded into a 500 µl eppendorf tube with
PBS/BSA/EDTA and diluted to 100 µl in the same buffer.
10  µl was removed and stained with DAPI to get an
approximate cell count. The other 90 µl was treated with
the microbeads as described above. After cell separation,
cells were mixed 1:1 with 10% buffered Formalin on a
poly-l-lysine coated Mattek dish and stained for anti-pan-
keratin and anti-F480.
Real Time PCR was performed on mRNA isolated from
the collected cells before and after microbead separation
using macrophage (MAC-1) and carcinoma cell (keratin)
specific primers.
Conventional total RNA extraction and microarray 
hybridization
For isolation of RNA from large numbers of cultured cells,
standard RNA extraction and microarrays hybridization
we followed standard protocols as described elsewhere
[6,16].
RNA Extraction and cDNA amplification from small 
numbers of cells and microneedle collection samples
Cell collection was performed using needles with 25 nM
EGF [5], followed by microbead separation. Cells col-
lected from each needle were divided into 1/10 of the col-
lection volume for counting. The remaining 9/10 of cells
from the microneedle were placed into a 1.5-ml microcen-
trifuge tube containing 350 µl of guanidine thiocyanate
buffer, homogenized by passing the lysate through a 20-G
needle, attached to a sterile plastic syringe, at least 5–10
times. 500 µl of double-distilled water and 10 µl of
Qiagen Proteinase K solution was added to the homoge-
nate and mixed thoroughly by pipeting and incubated at
55°C for 10 minutes. Extraction was continued using the
RNeasy kit (QIAGEN), and RNA molecules selectively
bound to the silica gel base were eluted with 30 µl RNase-
free water. The RNA was then concentrated by ethanol
precipitation and re-dissolved in 3.5 ul DEPC water.
The total RNA was reverse-transcribed directly using the
SMART PCR cDNA synthesis kit (Clontech, Palo Alto, CA)
according to the manufacturer's protocol. Annealing was
conducted using a modified oligo(dT) at 70°C for 2 min-
utes in the presence of the SMART II oligonucleotide in a
total volume of 5.5 µl. The reaction was followed by the
addition of Superscript II (200 units) RNase H- reverse
transcriptase (RT) (Gibco-BRL, Gaithersburg, MD) and
incubated at 42°C for 1 hour. The reaction was stopped
by adding 40 µl of Tris-EDTA buffer and heatingat 72°C
for 7 minutes. Representative double-stranded cDNAs
were then generated by exponential PCR amplification.
The optimal number of cycles for each sample was deter-
mined by analyzing the PCR products of a series of PCR
amplifications using different numbers of cycles by elec-
trophoresis. Four microliters from the 50-µl single-
stranded cDNA stocks were amplified in 50-µl reactions
using the SMART PCR primer by the predetermined expo-
nential number of cycles. Amplified cDNAs from the cells
of the primary tumor and needle collection were diluted
and used for further analysis by cDNA microarrays and
real-time PCR.
Microarray hybridization and analysis
Microarray analysis was performed by using cDNA micro-
arrays made at AECOM. About 9,700 mouse genes (Incyte
Genomics) were precisely spotted onto a single glass slide.
Detailed descriptions of microarray hardware and proce-
dures are available from http://www.aecom.yu.edu/can
cer/new/cores/microarray/default.htm.
After amplification, cDNAs were purified using the
QIAquick PCR Purification Kit (Qiagen) and eluted with
TE buffer. For each probe, labeling was conducted by
incorporation of Cy5 or Cy3-dUTP (Amersham Pharma-
cia) during random hexamer-primered primer extentionBMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/13
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in the presence of Klenow DNA polymerase (Life Technol-
ogy). Briefly, 2.5 µg dscDNA was mixed with 3 µl (0.5 µg/
µl) random primer, adjusted to 23 µl, boiled at 95°C for
5 minutes, and put on ice. The above was then mixed with
3 µl reaction 2 buffer (Biolabs), 3 µl 10X dNTP (1.2 mM
dCTP, dGTP and dATP, 0.6 mM dTTP), 3 µl Cy5 dUTP and
1 µl Klenow DNA polymerase and incubated at 37°C for
2 hours and stopped with EDTA. The two resulting cDNA
probes were then mixed together, purified and concen-
trated, denatured at 94°C, and hybridized to an arrayed
slide overnight at 50°C. Details of slide washing, image
collection and data normalization and analysis were
described in previous study [16]. In this study, compari-
sons of normalized data were graphed using Log2 (ch1/
ch2) ratio scatter plots. The linear regression function in
Excel was used to calculate R2 (the correlation coefficient).
Quantitative Real-Time PCR (QRT-PCR)
Quantitative RT-PCR analysis of the abundance of mRNA
in cell and tissue samples was performed by using the iCy-
cler apparatus (Bio-Rad) with sequence specific primer
pairs for selected genes. The SYBR Green PCR Core Rea-
gents system (Perkin-Elmer Applied Biosystems) was used
for real-time monitoring of amplification. Results were
evaluated with the ICYCLER IQ REAL TIME DETECTION
SYSTEM software (Bio-Rad) [16].
Quality control of the RNA prepared from cells collected 
in microneedles
Total RNA from cells in microneedles was extracted. To
verify successful RNA isolation and the intactness of the
RNA samples, the RNA 6000 Pico kit and Agilent 2100
Bioanalyzer (Agilent Technologies) were used. The system
automatically calculates the ratio of ribosomal bands in
total RNA samples and shows the percentage of ribosomal
impurities in RNA samples.
Total RNA from mammary tumors of MMTV-PyMT mice
was prepared, and different amounts of RNA (correlated
with the numbers of cells, 30 pg/cell) were used to gener-
ate a standard curve by real-time PCR. The abundance of
β-actin mRNA was measured by the CT (threshold cycle)
values of the real time PCR reaction. Cells were collected
from  MMTV-PyMT  tumors of the mammary using the
microneedle technique. One fourth of the cDNA (equiva-
lent to that from 200 and 400 cells, in three repeats) from
two independent cell collection experiments was used in
real-time PCR with the same β-actin primers used to con-
struct the standard curve. The CT values for these two sam-
ples were fit to the standard curve.
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